JU

Jubilant Pharmova LtdNSE JUBLPHARMA Stock Report

Last reporting period 31 Mar, 2024

Updated 04 Nov, 2024

Last price

Market cap $B

1.33

Small

Exchange

XNSE - National Stock Exchange Of India

View Section: Price ratios

Jubilant Statements

JU

Data from Jubilant`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2024

Next reporting period:

27 Sep, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

25 Oct, 2024

Jubilant Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

34 357

5.2 %

100

10 633

30

23 724

8.3 %

70

0

11 365

31.6

20 786

5.8 %

60.3

2 938

30.5 %

9.7

-1 278

-4

502

0.8

473

-61.6 %

-3.05

427

0.5

82

-88.1 %

-3.3

0.484

158.36

2023-09-30
%

32 672

1.1 %

100

10 774

33.2

21 898

-1.5 %

66.8

0

10 795

31.6

19 647

-11.6 %

58.2

2 251

54210.6 %

8.6

-1 204

-3.4

185

0.6

1 232

258.5 %

5.8

551

2.1

689

160.7 %

3.7

4.34

159.31

2023-03-31
%

32 304.98

5.9 %

100

10 078.8

31.6

22 226.18

1.9 %

68.4

0

11 022

31.8

22 230.34

13.5 %

71.5

-4.16

-100.2 %

-3.1

-911.44

-2.3

139.47

0.3

-777.09

-173.7 %

-5.1

389.02

0.8

-1 135.4

-316.3 %

-5.8

-7.097

159.98

2022-09-30
%

30 512

7.5 %

100

8 701

30.2

21 811

1.5 %

69.8

0

10 638

33.4

19 585

3 %

62

2 226

-10.1 %

7.8

-848

-2.8

244

0.8

1 055

-40 %

2.3

538

2

525

-52.5 %

0.3

3.3

160

2022-03-31
%

28 380

-13.8 %

100

6 882

27.2

21 499

-13.7 %

72.9

0

10 349

33.4

19 021

-3.2 %

63.2

2 477

-53 %

9.6

-748

-2.5

29

-0.2

1 759

-61.3 %

6.9

660

3.1

1 105

-63.6 %

3.9

6.94

159

2021-09-30
%

32 922

-1.8 %

100

7 998

26.5

24 922

-0.5 %

73.5

0

10 372

30.7

19 654

8.1 %

59

5 269

-23.1 %

14.5

-807

-2.2

84

0.3

4 545

-23.7 %

12.5

1 514

3.9

3 034

-42.1 %

8.6

19.06

159

2021-03-31
%

33 511

22 %

100

8 475

24.6

25 036

21.6 %

75.4

0

10 143

32

18 184

7.2 %

57.1

6 851

89.1 %

18.2

-785

-1.8

103

0.4

5 958

116.4 %

16.2

2 043

5.3

5 238

67.9 %

13.5

32.94

159

2020-09-30
%

27 475

-11 %

100

6 886

28.1

20 589

-11.3 %

71.9

0

9 649

29.5

16 965

2.5 %

55.3

3 623

-45.6 %

16.6

-944

-2.9

74

0.2

2 753

-50.7 %

13.9

930

4.7

3 120

-32.7 %

14.1

19.44

160

2020-03-31
%

30 865

6.8 %

100

7 643

25.9

23 223

5.6 %

74.1

0

10 088

32.9

16 557

-0.1 %

52.4

6 665

23.1 %

21.7

-958

-3

205

1.1

5 583

22.8 %

19.8

2 097

7.6

4 639

6.8 %

16.6

29.17

159

2019-09-30
%

28 893

-39.3 %

100

6 910

-9.08

21 983

-24.6 %

109.1

0

9 466

46.7

16 567

-26.2 %

79.4

5 416

-19 %

29.6

-1 039

-4.4

169

1

4 545

44 %

26.2

1 973

16

4 344

169 %

35.3

27.12

160

2019-03-31
%

47 627

9.5 %

100

18 484

40.8

29 142

9 %

59.2

0

12 440

25.6

22 459

14.3 %

48

6 684

-5.9 %

11.2

-844

-0.7

224

-0.3

3 156

-46.3 %

-1.7

1 488

2.5

1 615

-60.9 %

-4.2

10.35

156

2018-09-30
%

43 482

100

16 734

38.7

26 747

61.3

0

11 483

26.3

19 645

45.5

7 103

15.9

-1 354

-2.8

133

0.2

5 882

13.3

1 780

4.1

4 129

9.3

26.48

156

View Section: Balance Sheet